Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)-Reference-Cited by-同舟云学术

Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

Published:2015-08-04 Issue:1 Volume:46 Page:3-9
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Kudo Masatoshi¹,Ueshima Kazuomi¹,Kubo Shoji¹,Sakamoto Michiie¹,Tanaka Masatoshi¹,Ikai Iwao¹,Furuse Junji¹,Murakami Takamichi¹,Kadoya Masumi¹,Kokudo Norihiro¹,

Affiliation:

1. Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan, Department of Gastroenterology and Hepatology; Kinki University School of Medicine; Osaka-Sayama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12542/fullpdf

Reference10 articles.

1. Response evaluation criteria in cancer of the liver;Liver Cancer Study Group of Japan;Kanzo,1994

2. Response evaluation criteria in cancer of the liver;Liver Cancer Study Group of Japan;Kanzo,2004

3. Liver cancer study group of Japan, response evaluation criteria in cancer of the liver (2009 revised version);Kudo;Kanzo,2010

4. Response evaluation criteria in cancer of the liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version);Kudo;Hepatol Res,2010

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma;Cancers;2024-04-23

2. Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma;Anticancer Research;2024-03-27

3. Surgical intervention after lenvatinib treatment in patients with advanced hepatocellular carcinoma;2023-10-30

4. Report of the 23rd nationwide follow‐up survey of primary liver cancer in Japan (2014–2015);Hepatology Research;2023-09-05

5. 第23回全国原発性肝癌追跡調査報告（2014～2015）;Kanzo;2023-08-01